[go: up one dir, main page]

AU2961199A - Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection - Google Patents

Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection

Info

Publication number
AU2961199A
AU2961199A AU29611/99A AU2961199A AU2961199A AU 2961199 A AU2961199 A AU 2961199A AU 29611/99 A AU29611/99 A AU 29611/99A AU 2961199 A AU2961199 A AU 2961199A AU 2961199 A AU2961199 A AU 2961199A
Authority
AU
Australia
Prior art keywords
hiv
infection
preventing
medicinal compositions
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29611/99A
Inventor
Toru Kimura
Kazuyuki Takai
Hiroshi Takaku
Akira Wada
Naoki Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MARINE BIO CO Ltd
Original Assignee
MARINE BIO CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MARINE BIO CO Ltd filed Critical MARINE BIO CO Ltd
Publication of AU2961199A publication Critical patent/AU2961199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU29611/99A 1998-04-02 1999-04-01 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection Abandoned AU2961199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/125452 1998-04-02
JP10125452A JPH11292795A (en) 1998-04-02 1998-04-02 Hiv cofactor inhibitor
PCT/JP1999/001722 WO1999051751A1 (en) 1998-04-02 1999-04-01 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection

Publications (1)

Publication Number Publication Date
AU2961199A true AU2961199A (en) 1999-10-25

Family

ID=14910450

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29611/99A Abandoned AU2961199A (en) 1998-04-02 1999-04-01 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection

Country Status (3)

Country Link
JP (1) JPH11292795A (en)
AU (1) AU2961199A (en)
WO (1) WO1999051751A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
EP1050583A4 (en) * 1998-11-24 2005-02-02 Hisamitsu Pharmaceutical Co Hiv infection inhibitors
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
EP2000160A3 (en) * 2002-10-30 2009-03-11 Gambro Lundia AB Method and apparatuses for determining the efficiency of dialysis
WO2005105841A2 (en) 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
TWI428135B (en) * 2007-03-26 2014-03-01 Hirofumi Takeuchi And a carrier composition for quick-acting nucleic acid delivery
UA97559C2 (en) 2007-11-08 2012-02-27 Оцука Фармасьютікал Ко., Лтд. Nucleic acid complex and a nucleic acid delivery composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6012375A (en) * 1993-07-06 2000-01-11 Eckstein; Donald B. Aircraft infrared guided defense missile system
US5417978A (en) * 1993-07-29 1995-05-23 Board Of Regents, The University Of Texas System Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use
US6197578B1 (en) * 1996-01-30 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection

Also Published As

Publication number Publication date
JPH11292795A (en) 1999-10-26
WO1999051751A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
AU2951299A (en) Disinfecting compositions and processes for disinfecting surfaces
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
HUP0101204A3 (en) Hiv inhibiting pyrimidine derivatives and pharmaceutical compositions containing them
AU3572599A (en) Analgesic compositions comprising nmda-antagonists and abt-594
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU1933500A (en) Quinoline-indole antimicrobial agents, uses and compositions related thereto
IL175723A0 (en) Pharmaceutical compositions and kits containing androst-5-ene-3??, 17??-diol or prodrugs thereof
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
HUP0104410A3 (en) A composition for the prevention and/or treatment of atherosclerosis
HUP0102255A3 (en) Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
AU2046900A (en) Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
AU1800600A (en) Ume extract having medicinal effects and compositions containing the same
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU5565099A (en) Pharmaceutical compositions and methods for use
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
HUP0103382A2 (en) Naaladase inhibitors useful as pharmaceutical compounds and compositions
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU1408300A (en) Hiv infection inhibitors
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
AU4505199A (en) Methods and compositions for increasing penetration of hiv protease inhibitors
AU3999599A (en) Polyolefin compositions having variable toughness and/or hardness
AU2961199A (en) Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection
AUPP589398A0 (en) Immunogenic compositions and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase